103 related articles for article (PubMed ID: 6178499)
1. Carcinoma of type II pneumocytes. PAS staining as a screening test for nuclear inclusions of surfactant specific apoprotein.
Singh G; Katyal SL; Torikata C
Cancer; 1982 Sep; 50(5):946-8. PubMed ID: 6178499
[TBL] [Abstract][Full Text] [Related]
2. Type II pneumocytes in pulmonary tumors. Implications for histogenesis.
Singh G; Katyal SL; Ordonez NG; Dail DH; Negishi Y; Weedn VW; Marcus PB; Weldon-Linne CM; Axiotis CA; Alvarez-Fernandez E
Arch Pathol Lab Med; 1984 Jan; 108(1):44-8. PubMed ID: 6318684
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological analysis of surfactant-apoprotein in the bronchiolo-alveolar carcinoma.
Dairaku M; Sueishi K; Tanaka K; Horie A
Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):223-34. PubMed ID: 6310856
[TBL] [Abstract][Full Text] [Related]
4. The pathobiologic features of carcinomas of type II pneumocytes. An immunocytologic study.
Singh G; Scheithauer BW; Katyal SL
Cancer; 1986 Mar; 57(5):994-9. PubMed ID: 2417691
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma of type II pneumocytes: immunodiagnosis of a subtype of "bronchioloalveolar carcinomas".
Singh G; Katyal SL; Torikata C
Am J Pathol; 1981 Feb; 102(2):195-208. PubMed ID: 6258440
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung.
Kitinya JN; Sueishi K; Tanaka K; Katsuda Y
Acta Pathol Jpn; 1986 Sep; 36(9):1271-8. PubMed ID: 3024446
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of lung adenocarcinoma using monoclonal antibody for 60-kilodalton antigen in type II pneumocytes and nonciliated bronchiolar epithelial cells. Comparison with two antisurfactant apoprotein antibodies.
Suehiro T; Maeda K; Sueishi K
Am J Clin Pathol; 1989 Aug; 92(2):150-8. PubMed ID: 2547307
[TBL] [Abstract][Full Text] [Related]
8. Surfactant apoprotein in nonmalignant pulmonary disorders.
Singh G; Katyal SL
Am J Pathol; 1980 Oct; 101(1):51-61. PubMed ID: 7004201
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas.
Mizutani Y; Nakajima T; Morinaga S; Gotoh M; Shimosato Y; Akino T; Suzuki A
Cancer; 1988 Feb; 61(3):532-7. PubMed ID: 3338020
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies.
Dempo K; Satoh M; Tsuji S; Mori M; Kuroki Y; Akino T
Pathol Res Pract; 1987 Oct; 182(5):669-75. PubMed ID: 2825147
[TBL] [Abstract][Full Text] [Related]
11. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
12. [Bronchiolo-alveolar carcinoma]. Histologic analysis of 3 cases, one of which with ultrastructural study].
Linoli O; Ventura P
Pathologica; 1994 Oct; 86(5):513-24. PubMed ID: 7739877
[TBL] [Abstract][Full Text] [Related]
13. CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes.
Salaun B; de Saint-Vis B; Pacheco N; Pacheco Y; Riesler A; Isaac S; Leroux C; Clair-Moninot V; Pin JJ; Griffith J; Treilleux I; Goddard S; Davoust J; Kleijmeer M; Lebecque S
Am J Pathol; 2004 Mar; 164(3):861-71. PubMed ID: 14982840
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells.
Nagata N; Dairaku M; Sueishi K; Tanaka K
Am J Clin Pathol; 1987 Nov; 88(5):552-9. PubMed ID: 2823596
[TBL] [Abstract][Full Text] [Related]
15. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
16. [Alveolar adenoma of the lung. Immunohistochemical characterization of type II pneumocytes].
Köppl H; Freudenberg N; Berwanger I; Frenzer K; Böhm N
Pathologe; 1996 Mar; 17(2):150-3. PubMed ID: 8650145
[TBL] [Abstract][Full Text] [Related]
17. Bronchiolo-alveolar carcinoma with nuclear tubular inclusions. Case report and electron microscopy findings.
Matoska J; Bayer A; Dianovsky D
Zentralbl Allg Pathol; 1986; 131(4):371-8. PubMed ID: 3014785
[TBL] [Abstract][Full Text] [Related]
18. [Cytomorphologic criteria of bronchioloalveolar cell cancer].
de Masi D; Atay Z
Pneumologie; 1990 Feb; 44 Suppl 1():610-1. PubMed ID: 2164208
[TBL] [Abstract][Full Text] [Related]
19. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.
Clayton F
Cancer; 1986 Apr; 57(8):1555-64. PubMed ID: 3004694
[TBL] [Abstract][Full Text] [Related]
20. Origin of bronchioloalveolar carcinoma and peripheral bronchial adenocarcinoma.
Dermer GB
Cancer; 1982 Mar; 49(5):881-7. PubMed ID: 6277455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
